Almonds, Gut Microbiome and Kids
NCT07636850 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70
Last updated 2026-06-09
Summary
This 8-week parallel-arm randomized controlled trial (N=70; ages 6-13) will determine the impact of daily almond butter consumption on gut microbiome composition and function, intestinal barrier integrity, and cardiometabolic health in school-aged children. Participants will be randomized to either a once-daily snack of personalized-portion almond butter (ALB; 16g, Creamy Natural Almond Butter) or an isocaloric nut-free chocolate spread control (CTL; 16g, Cadbury Milk Chocolate), each served on two plain unsalted saltine crackers, added to their habitual diet. The primary outcomes include oro-gut microbial composition and diversity, gut microbial functional capacity and metabolomics (SCFAs, bile acids, amino acid metabolites), and intestinal barrier integrity. Secondary outcomes include fasting cardiometabolic markers, systemic inflammation, appetite-regulatory and metabolic hormones, and sleep-related biomarkers. Feasibility, adherence (weekly logs; serum α-tocopherol), and precision nutrition potential will also be assessed, with stratified analyses by age, sex, BMI, ethnicity, and pubertal stage.
This pilot trial will generate the first multi-omics characterization of almond butter's effects on the gut-immune-metabolic axis in children.
Conditions
- Dysbiosis
- Cardiometabolic Health Indicators
Interventions
- OTHER
-
Creamy Richards 100% Almonds! Creamy Natural Almond Butter
Almond Butter (ALB) Group: Participants in this group will receive a daily snack consisting of a personalized portion of smooth natural almond butter (Creamy Richards 100% Almonds! Creamy Natural Almond Butter) spread between two plain unsalted saltine crackers (Unsalted Tops Premium Saltine Crackers). The amount of almond butter will be limited to 16g per two crackers; additional crackers will be provided if the personalized portion exceeds this limit.
- OTHER
-
Cadbury Milk Chocolate Spread
Control (CTL) Group: Participants in this group will receive a daily snack consisting of an isocaloric amount of a nut-free, vegetable oil-based chocolate spread ("Cadbury Milk Chocolate") spread between two plain unsalted saltine crackers ("Unsalted Tops Premium Saltine Crackers"). Similar to the peanut butter group, the chocolate spread will be limited to 16g per two crackers, with additional crackers provided if needed.
Sponsors & Collaborators
-
Almond Board of California
collaborator OTHER -
Florida State University
lead OTHER
Principal Investigators
-
Ravinder Nagpal, PhD · Florida State University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Years
- Max Age
- 13 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-08-01
- Primary Completion
- 2028-08-31
- Completion
- 2028-12-31
Countries
- United States
Study Locations
More Related Trials
-
Impact of Consuming a Plant-based Enriched Meal on the Adult Gut Microbiome
NCT05459662 ·Status: COMPLETED ·Phase: NA
-
Effect of Strawberry Consumption on the Microbiome
NCT04217122 ·Status: COMPLETED ·Phase: NA
-
A Multi-Strain Probiotic Reduces the Frequency of Diarrhea in IBS-D Patients
NCT05900752 ·Status: COMPLETED ·Phase: NA
-
Effects of Pre-, Pro- & Anti-biotics on Gut Microbiota
NCT01414010 ·Status: COMPLETED ·Phase: NA
-
Gut Microbiome Associated Study of Shanghai Infants With Jaundice
NCT03510936 ·Status: UNKNOWN ·Phase: NA
-
Open-Label Clinical Trial Evaluating the Impact of a Multi-Strain Commensal Probiotic Dietary Supplement on Gastrointestinal Microbiota Composition, Functional Gastrointestinal Markers, and Gastrointestinal Symptoms
NCT07720362 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Rewilding the Human Gut: Reintroduction of the Species Limosilactobacillus Reuteri
NCT03501082 ·Status: COMPLETED ·Phase: NA
-
The Effects of a Postbiotic Supplement on Biomarkers of Gut Health
NCT07527286 ·Status: COMPLETED
-
Intestinal Microbiota: Immunity, Recovery and Metabolic Health
NCT06355089 ·Status: COMPLETED ·Phase: NA
-
Effects of an Encapsulated Calcium Butyrate Dietary Supplement on Gut Health
NCT06397482 ·Status: COMPLETED ·Phase: NA
-
Probiotics for the Prevention of Antibiotic-Associated Diarrhea
NCT02817165 ·Status: TERMINATED ·Phase: NA
-
An Intervention on Healthy Adults of Probiotics on Gut Flora Metabolisms of Choline
NCT03292978 ·Status: COMPLETED ·Phase: NA
-
Probiotics and Intestinal Microbiome in Preterm Infants
NCT03422562 ·Status: COMPLETED ·Phase: PHASE3
-
Determination of the Safety and Efficacy of Two Probiotic Strains
NCT06466174 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Probiotics in Reducing Infections and Allergies in Young Children During the Complementary Feeding Period
NCT02032056 ·Status: TERMINATED ·Phase: NA
-
Boosting Microbiota Butyrate Producers to Improve Gut Health
NCT07198984 ·Status: RECRUITING
-
Modulation of Microbial Composition in Ileostomy Patients
NCT02920294 ·Status: COMPLETED ·Phase: NA
-
Probiotics and Gut Health
NCT01874301 ·Status: COMPLETED ·Phase: NA
-
The Impact of Compound Probiotic Freeze-dried Powder on Enhancing Gastrointestinal Health
NCT07025798 ·Status: COMPLETED ·Phase: NA
-
Effect of Probiotic Administration on Gut Flora Composition
NCT03330678 ·Status: COMPLETED ·Phase: NA
-
Effect of Probiotics on the Digestibility and Immunity in Infants
NCT02317406 ·Status: COMPLETED ·Phase: NA
-
The Effect of 3 Probiotic Strains on Bile Acids, Satiety, and Inflammation
NCT01879098 ·Status: COMPLETED ·Phase: PHASE1
-
Dose Response Effect of Probiotics for the Prevention of Antibiotic-associated Diarrhea in Chinese Adults
NCT01143623 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Prebiotic Intake on Gut Microbiota in Healthy Adults
NCT03042494 ·Status: COMPLETED ·Phase: NA
-
Influence of GanedenBC30 (Bacillus Coagulans GBI-30, 6086) on the Gut Microbiome in Healthy Adults
NCT02872688 ·Status: COMPLETED ·Phase: NA